{"schema_version":"secwatch.filing_event.v1","accession":"0000914121-22-002826","form_type":"8-K","ticker":"ANGO","cik":"0001275187","company_name":"ANGIODYNAMICS INC","filed_at":"2022-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.058194+00:00","generated_at":"2026-06-26T08:42:12.232609+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"AngioDynamics Q3 net sales $74.0M (+3.9% YoY); GAAP EPS -$0.13, adjusted $0.03; reaffirms FY guidance","bullets":["Net sales $74.0M (+3.9% YoY); Med Tech +28.6% driven by Auryon ($7.3M) and thrombectomy; Med Device -2.8%.","Gross margin 52.2%, down 190bps YoY on inflation, labor, supply chain; net loss $5.0M ($0.13/sh) vs $3.5M loss prior year.","Adjusted EPS $0.03 (incl. $4.2M CARES Act benefit); adjusted EBITDA $6.7M vs $5.4M a year ago.","Reaffirmed FY2022 guidance: sales $310-315M, gross margin 52-54%, adjusted EPS -$0.02 to $0.02.","Post-quarter: FDA cleared AlphaVac F18 for venous use; IDE approved for pulmonary embolism; PRESERVE prostate trial enrolled."],"urls":{"canonical":"https://secwatch.observer/filing/0000914121-22-002826","json":"https://secwatch.observer/filing/0000914121-22-002826.json","markdown":"https://secwatch.observer/filing/0000914121-22-002826.md","text":"https://secwatch.observer/filing/0000914121-22-002826.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1275187/000091412122002826/0000914121-22-002826-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1275187/000091412122002826/an57733391-8ki.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T08:42:12.232609+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}